GlassScriptPhysician profile
Colene M Smith
NPI 1730665670
$874.07
in general payments reported to CMS, 2019-2025
13 companies · $33.96 in 2025
The $33.96 reported for 2025 was less than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $233 · 2022: $341 · 2023: $99.31 · 2024: $167 · 2025: $33.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $300.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $250.86 | 2021-2025 | |
| Myovant Sciences INC. | $190.39 | 2021-2022 | |
| Novo Nordisk INC | $106.50 | 2021-2024 | Wegovy |
| Amgen INC. | $80.40 | 2021-2023 | Prolia |
| Hologic Sales and Service, LLC | $48.93 | 2024 | Aptima, Acessa Provu System |
| Optumhealth Care Solutions, LLC | $32.87 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Organon LLC | $32.25 | 2023-2024 | Nexplanon |
| Coopersurgical, INC. | $31.51 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $30.00 | 2021 | |
| Agile Therapeutics, INC. | $27.26 | 2021-2023 | Twirla |
| Scynexis, INC. | $15.64 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $14.86 | 2023 | Vivjoa |
| Biohaven Pharmaceutical Holding Company LTD. | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colene Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.